NCT03491605Recruiting
Surveillance and Tracking the Outcomes of Chronic Latent EBV Infection
Study to Surveil and Track the Outcomes of Chronic Latent EBV Infection Based on Healthy Volunteers Undergoing Routine Inspection
Source: ClinicalTrials.gov · Last updated 10 Feb 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Immunocompetent subjects with high load of Epstein-Barr virus DNA (EBV-DNA) in peripheral blood will be enrolled and prospectively followed up to track the natural histories of the chronic high load of EBV virus. The primary goal of this study is to explore the association of peripheral high load of EBV with the hematological malignancies, and second goal is to investigate the genetic mechanisms of immune escape and tumorigenesis of chronic EBV infection.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 10000 (estimated)
- First submitted
- 2 Apr 2018
- Start date
- 1 Jul 2019
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Huazhong University of Science and Technology
- NCT number
- NCT03491605
What you commit to
- Study type: Observational
- Planned participants: 10000
- From 1 Jul 2019 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Subjects who have taken or are going to take immunosuppressive drugs.
Other illness
- Subjects diagnosis as precancerous lesion or malignant tumor and the life expectancy is less than 1 year.
- psychological illness which does not allow subjects to understand the study and participate following his own free will
Other
- Subjects with defined immunodeficiency
- Subjects Diagnosed a validated hematopathy
- Pregnant woman
- no written informed consent
Who the study is looking for
- immunocompetent subjects who was found to have high EBV-DNA load （\>1×103 copies/ml）in peripheral blood during the physical examination
- Willing to be followed up by telephone or face-to-face interview
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tongji hospital, Tongji medical collage of HUST Coordinator of this site? Confirm its status | Wuhan | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.